The Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium) has filed notifications regarding changes in its membership with the Attorney General and the Federal Trade Commission. This was done under the National Cooperative Research and Production Act of 1993, which helps limit the damages antitrust plaintiffs can recover under certain conditions. Several new companies and organizations have joined the consortium, but no other changes have been made to its membership or planned activities. The consortium intends to continue updating its membership changes as they occur.
Simple Explanation
The Biopharmaceutical Manufacturing Preparedness Consortium is a group that makes medicine and is telling the government about new friends joining their club to make sure they follow the rules.